Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colonography, Computed Tomographic | 36 | 2020 | 170 | 9.310 |
Why?
|
Colonic Polyps | 20 | 2020 | 556 | 3.150 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 17 | 2014 | 1224 | 2.310 |
Why?
|
Radiographic Image Enhancement | 15 | 2014 | 872 | 1.870 |
Why?
|
Feces | 15 | 2018 | 1504 | 1.780 |
Why?
|
Pattern Recognition, Automated | 12 | 2014 | 978 | 1.490 |
Why?
|
Colon | 9 | 2021 | 1795 | 1.180 |
Why?
|
Liquid Crystals | 5 | 2019 | 20 | 1.020 |
Why?
|
Subtraction Technique | 6 | 2014 | 512 | 0.960 |
Why?
|
Imaging, Three-Dimensional | 16 | 2012 | 4034 | 0.880 |
Why?
|
Diagnosis, Computer-Assisted | 11 | 2023 | 698 | 0.880 |
Why?
|
Cisplatin | 3 | 2017 | 1658 | 0.870 |
Why?
|
Artifacts | 7 | 2014 | 1893 | 0.840 |
Why?
|
Deglutition | 1 | 2023 | 208 | 0.740 |
Why?
|
Cathartics | 6 | 2018 | 129 | 0.710 |
Why?
|
Carcinoma, Hepatocellular | 5 | 2015 | 2329 | 0.700 |
Why?
|
Colorectal Neoplasms | 6 | 2018 | 6942 | 0.640 |
Why?
|
Artificial Intelligence | 9 | 2023 | 2659 | 0.610 |
Why?
|
Sensitivity and Specificity | 25 | 2021 | 14652 | 0.590 |
Why?
|
Tomography, X-Ray Computed | 15 | 2021 | 20659 | 0.570 |
Why?
|
Liver Neoplasms | 5 | 2015 | 4353 | 0.560 |
Why?
|
Ovarian Neoplasms | 7 | 2020 | 4900 | 0.560 |
Why?
|
Contrast Media | 12 | 2018 | 5329 | 0.530 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 3 | 2014 | 208 | 0.520 |
Why?
|
Organoplatinum Compounds | 1 | 2017 | 404 | 0.510 |
Why?
|
Laxatives | 3 | 2012 | 94 | 0.470 |
Why?
|
Abdomen | 1 | 2020 | 1134 | 0.460 |
Why?
|
Matrix Metalloproteinase 7 | 5 | 2007 | 60 | 0.440 |
Why?
|
False Positive Reactions | 10 | 2012 | 955 | 0.440 |
Why?
|
User-Computer Interface | 3 | 2012 | 1405 | 0.430 |
Why?
|
Colonoscopy | 5 | 2020 | 1406 | 0.420 |
Why?
|
Refractometry | 2 | 2014 | 57 | 0.420 |
Why?
|
Pneumothorax | 3 | 2012 | 392 | 0.420 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2020 | 8923 | 0.410 |
Why?
|
Iohexol | 2 | 2013 | 204 | 0.400 |
Why?
|
Air | 1 | 2013 | 181 | 0.400 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2007 | 276 | 0.390 |
Why?
|
Colonic Neoplasms | 6 | 2007 | 2531 | 0.390 |
Why?
|
Electronics, Medical | 1 | 2012 | 70 | 0.380 |
Why?
|
Algorithms | 15 | 2018 | 14071 | 0.380 |
Why?
|
Adenomatous Polyps | 1 | 2012 | 109 | 0.370 |
Why?
|
Reproducibility of Results | 20 | 2023 | 20124 | 0.350 |
Why?
|
Cation Transport Proteins | 1 | 2013 | 325 | 0.350 |
Why?
|
Matrix Metalloproteinase 2 | 5 | 2007 | 462 | 0.340 |
Why?
|
Pinus | 1 | 2009 | 16 | 0.340 |
Why?
|
Diatrizoate Meglumine | 1 | 2009 | 80 | 0.330 |
Why?
|
Barium Sulfate | 1 | 2009 | 180 | 0.310 |
Why?
|
Magnetic Resonance Angiography | 1 | 2015 | 1426 | 0.310 |
Why?
|
Lung | 3 | 2021 | 10033 | 0.310 |
Why?
|
Image Enhancement | 3 | 2009 | 2858 | 0.310 |
Why?
|
Photochemistry | 1 | 2008 | 238 | 0.300 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2012 | 445 | 0.290 |
Why?
|
Crystallization | 1 | 2008 | 521 | 0.290 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2013 | 5337 | 0.280 |
Why?
|
Nonlinear Dynamics | 1 | 2009 | 490 | 0.270 |
Why?
|
Adenoma | 1 | 2016 | 2152 | 0.250 |
Why?
|
Polymers | 2 | 2014 | 1621 | 0.250 |
Why?
|
Phantoms, Imaging | 6 | 2013 | 2475 | 0.250 |
Why?
|
Carcinoma | 1 | 2016 | 2312 | 0.240 |
Why?
|
Liver | 2 | 2020 | 7562 | 0.240 |
Why?
|
Adenocarcinoma, Clear Cell | 4 | 2013 | 218 | 0.240 |
Why?
|
Water | 2 | 2019 | 1417 | 0.240 |
Why?
|
Supine Position | 1 | 2005 | 209 | 0.230 |
Why?
|
Pyrroles | 3 | 2015 | 1119 | 0.230 |
Why?
|
Cystadenocarcinoma, Serous | 4 | 2013 | 479 | 0.230 |
Why?
|
Nanotechnology | 1 | 2010 | 703 | 0.230 |
Why?
|
Humans | 77 | 2023 | 765968 | 0.230 |
Why?
|
Prone Position | 1 | 2005 | 201 | 0.220 |
Why?
|
Antigens, Neoplasm | 2 | 2021 | 2002 | 0.220 |
Why?
|
Antineoplastic Agents | 5 | 2017 | 13648 | 0.220 |
Why?
|
Cluster Analysis | 3 | 2009 | 2721 | 0.210 |
Why?
|
ROC Curve | 8 | 2019 | 3620 | 0.210 |
Why?
|
Gallium | 1 | 2002 | 30 | 0.210 |
Why?
|
Metallothionein | 1 | 2002 | 62 | 0.200 |
Why?
|
Indoles | 3 | 2015 | 1839 | 0.200 |
Why?
|
Middle Aged | 37 | 2021 | 223009 | 0.190 |
Why?
|
Immunoenzyme Techniques | 5 | 2013 | 1701 | 0.190 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2009 | 3356 | 0.190 |
Why?
|
Cadmium | 1 | 2002 | 218 | 0.190 |
Why?
|
Aged | 31 | 2021 | 171117 | 0.180 |
Why?
|
Aged, 80 and over | 23 | 2021 | 59489 | 0.180 |
Why?
|
Endometrial Neoplasms | 5 | 2013 | 1378 | 0.180 |
Why?
|
Sacroiliitis | 1 | 2020 | 11 | 0.180 |
Why?
|
Fluorescent Antibody Technique | 3 | 2021 | 2476 | 0.180 |
Why?
|
Prognosis | 11 | 2021 | 29922 | 0.180 |
Why?
|
Sacroiliac Joint | 1 | 2020 | 58 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 5 | 2020 | 6499 | 0.170 |
Why?
|
Automation | 2 | 2021 | 585 | 0.170 |
Why?
|
Japan | 4 | 2018 | 1415 | 0.160 |
Why?
|
Radiography, Thoracic | 2 | 2004 | 1315 | 0.160 |
Why?
|
Staining and Labeling | 2 | 2014 | 1072 | 0.160 |
Why?
|
Female | 42 | 2021 | 396112 | 0.160 |
Why?
|
Spondylarthritis | 1 | 2020 | 62 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 5 | 2020 | 36532 | 0.160 |
Why?
|
Hospitals, University | 2 | 2018 | 574 | 0.160 |
Why?
|
Mass Screening | 2 | 2006 | 5446 | 0.150 |
Why?
|
Area Under Curve | 1 | 2023 | 1638 | 0.150 |
Why?
|
Fluoroscopy | 1 | 2023 | 947 | 0.150 |
Why?
|
Software | 2 | 2013 | 4462 | 0.150 |
Why?
|
Thorax | 1 | 2021 | 554 | 0.150 |
Why?
|
Nanoparticles | 1 | 2010 | 1964 | 0.150 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2013 | 521 | 0.150 |
Why?
|
Adult | 29 | 2021 | 223044 | 0.150 |
Why?
|
Microtubule-Associated Proteins | 1 | 2003 | 1066 | 0.140 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2007 | 2047 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11868 | 0.140 |
Why?
|
Survival Analysis | 3 | 2021 | 10070 | 0.140 |
Why?
|
Neoplasm Staging | 8 | 2020 | 11206 | 0.140 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15398 | 0.140 |
Why?
|
Immunochemistry | 1 | 2016 | 116 | 0.140 |
Why?
|
Angiogenesis Inhibitors | 3 | 2015 | 2056 | 0.140 |
Why?
|
Fractals | 2 | 2014 | 124 | 0.130 |
Why?
|
Patient Satisfaction | 1 | 2009 | 3475 | 0.130 |
Why?
|
Male | 30 | 2021 | 363698 | 0.130 |
Why?
|
Integrins | 1 | 2021 | 840 | 0.130 |
Why?
|
Single-Blind Method | 2 | 2009 | 1589 | 0.120 |
Why?
|
Liver Circulation | 1 | 2015 | 163 | 0.120 |
Why?
|
Kinetics | 2 | 2015 | 6274 | 0.120 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2017 | 194 | 0.120 |
Why?
|
Lung Neoplasms | 3 | 2019 | 13451 | 0.120 |
Why?
|
Membrane Proteins | 1 | 2011 | 7851 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3737 | 0.110 |
Why?
|
Quality Control | 3 | 2013 | 837 | 0.110 |
Why?
|
Retrospective Studies | 14 | 2020 | 81514 | 0.110 |
Why?
|
Disease-Free Survival | 4 | 2017 | 6832 | 0.110 |
Why?
|
Fuzzy Logic | 2 | 2004 | 58 | 0.110 |
Why?
|
Candidemia | 1 | 2014 | 46 | 0.110 |
Why?
|
Heat-Shock Proteins | 2 | 2008 | 791 | 0.110 |
Why?
|
Candida | 1 | 2014 | 172 | 0.100 |
Why?
|
Kidney | 2 | 2009 | 7066 | 0.100 |
Why?
|
Color | 1 | 2014 | 299 | 0.100 |
Why?
|
Pilot Projects | 3 | 2015 | 8733 | 0.100 |
Why?
|
Autoantibodies | 1 | 2021 | 2113 | 0.100 |
Why?
|
Benzimidazoles | 1 | 2017 | 864 | 0.100 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2009 | 2477 | 0.100 |
Why?
|
Maximum Tolerated Dose | 2 | 2017 | 898 | 0.100 |
Why?
|
Reference Standards | 3 | 2013 | 1013 | 0.100 |
Why?
|
Models, Chemical | 1 | 2014 | 608 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2009 | 1410 | 0.090 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2007 | 4044 | 0.090 |
Why?
|
Clostridium Infections | 1 | 2018 | 564 | 0.090 |
Why?
|
Nanopores | 1 | 2011 | 45 | 0.090 |
Why?
|
Candida albicans | 1 | 2014 | 377 | 0.090 |
Why?
|
Diagnostic Imaging | 2 | 2023 | 3529 | 0.090 |
Why?
|
Hemoglobins | 1 | 2016 | 1530 | 0.090 |
Why?
|
Sus scrofa | 1 | 2012 | 430 | 0.090 |
Why?
|
Radiation Dosage | 1 | 2018 | 1944 | 0.080 |
Why?
|
Survival Rate | 3 | 2014 | 12795 | 0.080 |
Why?
|
Cellulose | 1 | 2009 | 116 | 0.080 |
Why?
|
Thoracic Injuries | 1 | 2012 | 288 | 0.080 |
Why?
|
Response Elements | 1 | 2011 | 307 | 0.080 |
Why?
|
Information Storage and Retrieval | 2 | 2005 | 834 | 0.080 |
Why?
|
Biomass | 1 | 2009 | 136 | 0.080 |
Why?
|
Codon | 1 | 2011 | 595 | 0.080 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 586 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1915 | 0.080 |
Why?
|
Phase Transition | 1 | 2008 | 73 | 0.080 |
Why?
|
Temperature | 2 | 2019 | 2226 | 0.080 |
Why?
|
Hydrolysis | 1 | 2009 | 642 | 0.080 |
Why?
|
Radiography, Abdominal | 1 | 2012 | 544 | 0.080 |
Why?
|
Tooth | 1 | 2009 | 210 | 0.070 |
Why?
|
Neoplasm Invasiveness | 4 | 2005 | 3602 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2007 | 3513 | 0.070 |
Why?
|
Bacteriophage lambda | 1 | 2008 | 142 | 0.070 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2012 | 592 | 0.070 |
Why?
|
Catalysis | 1 | 2009 | 770 | 0.070 |
Why?
|
Glucose Transporter Type 3 | 1 | 2007 | 17 | 0.070 |
Why?
|
Normal Distribution | 1 | 2008 | 267 | 0.070 |
Why?
|
Calcium-Binding Proteins | 1 | 2012 | 1077 | 0.070 |
Why?
|
Lasers | 1 | 2011 | 951 | 0.070 |
Why?
|
X-Rays | 1 | 2008 | 310 | 0.070 |
Why?
|
Cachexia | 1 | 2009 | 200 | 0.070 |
Why?
|
Mouth | 1 | 2009 | 381 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2018 | 7478 | 0.070 |
Why?
|
Glucose Transporter Type 1 | 1 | 2007 | 185 | 0.070 |
Why?
|
Glucose Transporter Type 4 | 1 | 2007 | 240 | 0.070 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2007 | 636 | 0.070 |
Why?
|
Iopamidol | 1 | 2007 | 188 | 0.070 |
Why?
|
Adenocarcinoma | 2 | 2007 | 6364 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2017 | 5302 | 0.060 |
Why?
|
Multiple Organ Failure | 1 | 2009 | 390 | 0.060 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 705 | 0.060 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2008 | 393 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2005 | 97 | 0.060 |
Why?
|
Apoptosis | 3 | 2009 | 9514 | 0.060 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6113 | 0.060 |
Why?
|
Neurofibromatosis 2 | 1 | 2009 | 387 | 0.060 |
Why?
|
Lactobacillus | 1 | 2006 | 213 | 0.060 |
Why?
|
Cyclooxygenase 2 | 1 | 2007 | 594 | 0.060 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2005 | 120 | 0.060 |
Why?
|
Polyps | 1 | 2006 | 200 | 0.060 |
Why?
|
Microbial Sensitivity Tests | 3 | 2018 | 1971 | 0.060 |
Why?
|
Estrogens | 1 | 2011 | 1529 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13632 | 0.060 |
Why?
|
Neurofibromatosis 1 | 1 | 2009 | 560 | 0.060 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2004 | 139 | 0.050 |
Why?
|
Models, Molecular | 1 | 2014 | 5379 | 0.050 |
Why?
|
Neurilemmoma | 1 | 2009 | 522 | 0.050 |
Why?
|
Neoplasms, Experimental | 1 | 2009 | 1229 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 2012 | 1393 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2020 | 65188 | 0.050 |
Why?
|
Matrix Metalloproteinases | 1 | 2005 | 392 | 0.050 |
Why?
|
Computer Graphics | 1 | 2005 | 344 | 0.050 |
Why?
|
Maltose-Binding Proteins | 1 | 2002 | 62 | 0.050 |
Why?
|
Decision Support Systems, Clinical | 1 | 2012 | 1175 | 0.050 |
Why?
|
Adsorption | 1 | 2002 | 200 | 0.050 |
Why?
|
Age Factors | 2 | 2017 | 18380 | 0.050 |
Why?
|
Organ Size | 1 | 2007 | 2260 | 0.050 |
Why?
|
Discriminant Analysis | 1 | 2002 | 222 | 0.050 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2003 | 202 | 0.050 |
Why?
|
Neovascularization, Pathologic | 2 | 2014 | 2631 | 0.050 |
Why?
|
Adolescent | 8 | 2018 | 88835 | 0.050 |
Why?
|
Rectum | 1 | 2006 | 896 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2012 | 2968 | 0.050 |
Why?
|
Administration, Oral | 1 | 2009 | 4015 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2008 | 6493 | 0.050 |
Why?
|
Cell Line, Tumor | 4 | 2011 | 17075 | 0.050 |
Why?
|
False Negative Reactions | 1 | 2002 | 573 | 0.050 |
Why?
|
Escherichia coli Proteins | 1 | 2008 | 1057 | 0.050 |
Why?
|
Chelating Agents | 1 | 2002 | 380 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2012 | 3430 | 0.040 |
Why?
|
Swine | 2 | 2009 | 5988 | 0.040 |
Why?
|
Physicians, Family | 1 | 2003 | 349 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12509 | 0.040 |
Why?
|
Estradiol | 1 | 2007 | 1947 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2011 | 2942 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2006 | 1999 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2007 | 8611 | 0.040 |
Why?
|
Prospective Studies | 2 | 2016 | 54802 | 0.040 |
Why?
|
Regression Analysis | 1 | 2009 | 6322 | 0.040 |
Why?
|
Bacterial Proteins | 2 | 2018 | 3837 | 0.040 |
Why?
|
Gadolinium DTPA | 1 | 2002 | 823 | 0.040 |
Why?
|
Ribotyping | 1 | 2018 | 35 | 0.040 |
Why?
|
Escherichia coli | 2 | 2008 | 4214 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2021 | 870 | 0.040 |
Why?
|
ADP Ribose Transferases | 1 | 2018 | 90 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2004 | 12976 | 0.040 |
Why?
|
Young Adult | 6 | 2021 | 59889 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 1 | 2018 | 461 | 0.040 |
Why?
|
Forecasting | 1 | 2006 | 2936 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2004 | 1456 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10729 | 0.030 |
Why?
|
Genes, p53 | 2 | 2011 | 711 | 0.030 |
Why?
|
Metronidazole | 1 | 2018 | 236 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2005 | 1421 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 9373 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2018 | 471 | 0.030 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2003 | 790 | 0.030 |
Why?
|
Gastroenterology | 1 | 2003 | 594 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 2 | 2009 | 283 | 0.030 |
Why?
|
bcl-X Protein | 2 | 2009 | 414 | 0.030 |
Why?
|
Vancomycin | 1 | 2018 | 504 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2003 | 2887 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2021 | 3089 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2012 | 26346 | 0.030 |
Why?
|
Itraconazole | 1 | 2014 | 42 | 0.030 |
Why?
|
Binding Sites | 1 | 2002 | 6001 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3807 | 0.030 |
Why?
|
Low Back Pain | 1 | 2002 | 987 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2009 | 4958 | 0.030 |
Why?
|
Models, Statistical | 1 | 2008 | 5089 | 0.030 |
Why?
|
Drug Resistance, Fungal | 1 | 2014 | 79 | 0.030 |
Why?
|
Fluconazole | 1 | 2014 | 154 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4893 | 0.030 |
Why?
|
Perfusion Imaging | 1 | 2014 | 193 | 0.030 |
Why?
|
Patient Compliance | 1 | 2003 | 2692 | 0.020 |
Why?
|
Infant | 2 | 2012 | 36386 | 0.020 |
Why?
|
Scattering, Radiation | 1 | 2014 | 482 | 0.020 |
Why?
|
Cause of Death | 1 | 2003 | 3708 | 0.020 |
Why?
|
Animals | 5 | 2012 | 168764 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2014 | 493 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15880 | 0.020 |
Why?
|
Chest Tubes | 1 | 2012 | 153 | 0.020 |
Why?
|
Child, Preschool | 2 | 2012 | 42500 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2002 | 3046 | 0.020 |
Why?
|
Electricity | 1 | 2011 | 174 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2003 | 3596 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2003 | 2176 | 0.020 |
Why?
|
Anisotropy | 1 | 2014 | 1282 | 0.020 |
Why?
|
Ameloblasts | 1 | 2009 | 17 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 40065 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11888 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 372 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2011 | 443 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2002 | 4913 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2009 | 439 | 0.020 |
Why?
|
Proline | 1 | 2011 | 453 | 0.020 |
Why?
|
Radiology | 1 | 2003 | 2090 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6069 | 0.020 |
Why?
|
Antifungal Agents | 1 | 2014 | 769 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2003 | 3181 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6763 | 0.020 |
Why?
|
Light | 1 | 2014 | 1365 | 0.020 |
Why?
|
Chronic Disease | 1 | 2002 | 9347 | 0.020 |
Why?
|
Arginine | 1 | 2011 | 933 | 0.020 |
Why?
|
United States | 2 | 2007 | 72903 | 0.020 |
Why?
|
Chromatography | 1 | 2006 | 187 | 0.020 |
Why?
|
Estrogen Receptor beta | 1 | 2007 | 171 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2009 | 281 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2003 | 4274 | 0.020 |
Why?
|
Drainage | 1 | 2012 | 1179 | 0.020 |
Why?
|
Potassium Chloride | 1 | 2006 | 229 | 0.020 |
Why?
|
Multiple Trauma | 1 | 2009 | 369 | 0.020 |
Why?
|
Child | 2 | 2012 | 80564 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2005 | 71 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10563 | 0.020 |
Why?
|
Thinness | 1 | 2009 | 482 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 150 | 0.020 |
Why?
|
Epithelium | 1 | 2009 | 1599 | 0.020 |
Why?
|
Endometrium | 1 | 2007 | 406 | 0.010 |
Why?
|
Dimerization | 1 | 2006 | 880 | 0.010 |
Why?
|
Infusions, Intra-Arterial | 1 | 2005 | 218 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2008 | 1495 | 0.010 |
Why?
|
Estrogen Receptor alpha | 1 | 2007 | 578 | 0.010 |
Why?
|
Consensus | 1 | 2013 | 3202 | 0.010 |
Why?
|
Erythropoietin | 1 | 2007 | 716 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22223 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6919 | 0.010 |
Why?
|
Transfection | 1 | 2011 | 5743 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2007 | 11022 | 0.010 |
Why?
|
Spleen | 1 | 2009 | 2296 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2920 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4562 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2242 | 0.010 |
Why?
|
Rabbits | 1 | 2009 | 4734 | 0.010 |
Why?
|
Blotting, Western | 1 | 2009 | 5020 | 0.010 |
Why?
|
Education, Medical | 1 | 2013 | 1746 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2007 | 12768 | 0.010 |
Why?
|
Societies, Medical | 1 | 2013 | 3956 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2006 | 3051 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9338 | 0.010 |
Why?
|
Regeneration | 1 | 2009 | 1517 | 0.010 |
Why?
|
Observer Variation | 1 | 2006 | 2615 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4247 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6255 | 0.010 |
Why?
|
Hot Temperature | 1 | 2006 | 1433 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2009 | 1855 | 0.010 |
Why?
|
Body Composition | 1 | 2009 | 2439 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7584 | 0.010 |
Why?
|
Body Weight | 1 | 2009 | 4622 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 74840 | 0.010 |
Why?
|
Myocardium | 1 | 2009 | 4760 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15543 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2007 | 3681 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 17594 | 0.010 |
Why?
|
Cell Movement | 1 | 2005 | 5194 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22332 | 0.010 |
Why?
|
Body Mass Index | 1 | 2009 | 13039 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 15652 | 0.000 |
Why?
|
Neoplasms | 1 | 2014 | 22340 | 0.000 |
Why?
|
Mice | 1 | 2009 | 81819 | 0.000 |
Why?
|